CAS: 346692-04-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-(4-butylphenyl)-4-fluorobenzenesulfonamide REF: AN-AG00CNHBCAS: 346692-04-4 | ≥98%(HPLC) | 146.00 €~658.00 € | Tue 21 May 24 |
 | DC260126 REF: TM-T7127CAS: 346692-04-4 | 98% | 54.00 €~213.00 € | Tue 28 May 24 |
 | DC260126 REF: 3D-WNA69204CAS: 346692-04-4 | Min. 95% | To inquire | Tue 02 Jul 24 |
N-(4-butylphenyl)-4-fluorobenzenesulfonamide
CAS:346692-04-4
Formula:
C16H18FNO2S
Purity:
≥98%(HPLC)
Molecular weight:
307.3830
Ref: AN-AG00CNHB
| 1g | 553.00 € | |
| 10mg | 147.00 € | |
| 50mg | 658.00 € | |
| 100mg | 146.00 € | |
| 250mg | 247.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
DC260126
CAS:346692-04-4
DC260126 is a small-molecule antagonist of FFA1 (GPR40)
Formula:
C16H18FNO2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
307.38
Ref: TM-T7127
| 5mg | 54.00 € | |
| 10mg | 71.00 € | |
| 25mg | 139.00 € | |
| 50mg | 213.00 € | |
| 1ml*10 (DMSO) | 58.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
DC260126
CAS:346692-04-4
DC260126 is an investigational drug for the treatment of human breast cancer. DC260126 is a …
Formula:
C16H18FNO2S
Purity:
Min. 95%
Molecular weight:
307.38 g/mol
Ref: 3D-WNA69204
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
